Cargando…
FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2
The FK506-binding protein 12 (FKBP12) is a cytoplasmic protein and has been reported to possess multiple functions in signaling transduction based on its interaction with different cellular targets. Here, we report that FKBP12 interacts with oncoprotein MDM2 and induces MDM2 degradation. We demonstr...
Autores principales: | Liu, T, Xiong, J, Yi, S, Zhang, H, Zhou, S, Gu, L, Zhou, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378873/ https://www.ncbi.nlm.nih.gov/pubmed/27617579 http://dx.doi.org/10.1038/onc.2016.331 |
Ejemplares similares
-
S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy
por: Qi, Mengxin, et al.
Publicado: (2023) -
FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer
por: Xing, Mingyou, et al.
Publicado: (2019) -
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
por: Liu, Tao, et al.
Publicado: (2015) -
Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
por: Du, Wei, et al.
Publicado: (2013) -
Correction: Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
por: Du, Wei, et al.
Publicado: (2013)